Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-2.08%
1,074.93
-22.88
-2.08%
—1,097.811,087.761,087.761,072.98——
SIXC
Communications
SIXC
Communications
SIXC
-0.36%
609.84
-2.19
-0.36%
—612.03612.03612.03608.44——
SIXE
Energy
SIXE
Energy
SIXE
+1.19%
1,234.90
+14.47
+1.19%
—1,220.431,221.991,240.271,221.99——
SIXI
Industrials
SIXI
Industrials
SIXI
-1.45%
1,734.21
-25.52
-1.45%
—1,759.521,754.311,754.311,729.03——
SIXM
Financials
SIXM
Financials
SIXM
+0.17%
632.59
+1.05
+0.17%
—631.54631.27633.99630.26——
SIXR
Staples
SIXR
Staples
SIXR
-0.23%
855.20
-1.96
-0.23%
—857.16858.91861.71855.20——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-1.49%
212.20
-3.21
-1.49%
—215.41215.41215.41211.92——
SIXT
Technology
SIXT
Technology
SIXT
-1.61%
3,555.83
-58.32
-1.61%
—3,614.153,556.243,556.243,516.86——
SIXU
Utilities
SIXU
Utilities
SIXU
-1.08%
898.48
-9.82
-1.08%
—908.30906.55906.55897.14——
SIXV
Health care
SIXV
Health care
SIXV
-0.40%
1,474.42
-5.98
-0.40%
—1,480.401,479.551,484.431,473.50——
SIXY
Discretionary
SIXY
Discretionary
SIXY
-1.40%
2,364.87
-33.50
-1.40%
—2,398.372,373.092,373.092,354.14——
CONCORDBIO:NSE
Concord Biotech Ltd
₹1,135.00
-0.44%
(-5.00) 1D
May 15, 3:30:00 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for CONCORDBIO...
Open
₹1,140.00
High
₹1,149.40
Low
₹1,112.70
Mkt. cap
118.74B
Avg. vol.
281.34K
Volume
67.97K
Dividend
0.94%
Quarterly dividend
₹2.67
Ex dividend date
Sep 3, 2025
P/E ratio
38.20
52-wk high
₹2,150.40
52-wk low
₹987.00
EPS
₹29.71
No. of employees
2K
News stories
From sources across the web
Profile
Concord Biotech Limited is an Indian biotechnology company headquartered in Ahmedabad. The company manufactures fermentation-based biopharmaceutical active pharmaceutical ingredients sold worldwide. It manufactures biopharmaceutical products across therapy segments such as immunosuppressant, oncology, antifungal, antibacterial and anthelmintic. It has two manufacturing facilities–at Dholka near Ahmedabad, which is approved by USFDA, and at Limbasi in Kheda district. Wikipedia
About Concord Biotech Ltd
CEO-
Employees1.57K
Founded2000
Headquarters-
SectorPharmaceutical industry
Websiteconcordbiotech.com
Next call in 7 days
Fri, May 22, 2:38 AM
Fiscal Period
Q4 2026
EPS / Est. (INR)
- / ₹8.90
Revenue / Est. (INR)
- / 3.74B
Fiscal Q4 2026 earnings call
Waiting for the earnings call
At a glance: upcoming earnings
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
4.30B
2.04B
2.47B
2.78B
Cost of goods sold
1.72B
745.80M
775.44M
941.71M
Cost of revenue
1.72B
745.80M
775.44M
941.71M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
389.66M
378.97M
444.56M
467.81M
Operating expense
741.16M
857.87M
994.14M
1.03B
Total operating expenses
2.46B
1.60B
1.77B
1.98B
Operating income
1.84B
436.20M
701.00M
802.34M
Other non operating income
-307.08M
136.78M
133.52M
99.76M
EBT including unusual items
1.84B
587.32M
856.84M
861.56M
EBT excluding unusual items
1.62B
587.32M
856.84M
894.31M
Income tax expense
431.57M
146.74M
226.21M
225.14M
Effective tax rate
23.51%
24.98%
26.40%
26.13%
Other operating expenses
205.34M
301.13M
365.67M
378.34M
Net income
1.40B
440.58M
635.81M
644.77M
Net profit margin
32.66%
21.60%
25.74%
23.21%
Earnings per share
13.42
4.21
6.03
6.31
Interest and investment income
17.10M
-
-
-
Interest expense
-955.00K
-586.00K
-591.00K
-815.00K
Net interest expenses
16.15M
-586.00K
-591.00K
-815.00K
Depreciation and amortization charges
146.17M
177.76M
183.92M
187.47M
EBITDA
1.97B
572.14M
881.84M
933.85M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer